SCHEMBL202833

SCHEMBL202833

COc1cccc(-c2csc(COc3ccc(F)c(C(N)=O)c3F)n2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
ATP4A P20648 1/20 0.47
ATP4B P51164 1/20 0.47
ALDH1A1 P00352 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
HPGD P15428 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
PPARD Q03181 2/20 0.46
PPARA Q07869 2/20 0.46
MEN1 O00255 6/20 0.44
KMT2A Q03164 4/20 0.44
CSNK2A1 P68400 1/20 0.44
CYP19A1 P11511 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPT P10636 1/20 0.43
PAX8 Q06710 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL203683 0.88 POLB (0.43) POLBL3MBTL1ATP4AATP4BPPARD
SCHEMBL203280 0.88 L3MBTL1 (0.59) POLBL3MBTL1ATP4AATP4BALDH1A1
SCHEMBL201521 0.86 PPARD (0.49) POLBL3MBTL1ALDH1A1NPC1RAB9A
SCHEMBL19471118 0.84 L3MBTL1 (0.49) POLBL3MBTL1ALDH1A1NPC1RAB9A
SCHEMBL201522 0.84 NPC1 (0.42) NPC1RAB9ASMN1; SMN2PPARDPPARA
SCHEMBL204593 0.83 L3MBTL1 (0.46) POLBL3MBTL1NPC1RAB9AHTT
SCHEMBL201115 0.83 PPARD (0.44) L3MBTL1PPARDPPARAMAPT
SCHEMBL2707296 0.82 RAB9A (0.54) POLBL3MBTL1ALDH1A1NPC1RAB9A
SCHEMBL204423 0.82 L3MBTL1 (0.45) POLBL3MBTL1ALDH1A1NPC1RAB9A
SCHEMBL2705816 0.82 L3MBTL1 (0.53) POLBL3MBTL1ATP4AATP4BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250179008-A1 ANTIBACTERIAL AGENTS TAXIS PHARMACEUTICALS, INC. (US) 2025-06-05 US disclosed
US-20150191420-A1 ANTIBACTERIAL AGENTS TAXIS PHARMACEUTICALS, INC. 2015-07-09 US disclosed
US-20150191420-A1 ANTIBACTERIAL AGENTS TAXIS PHARMACEUTICALS, INC. 2015-07-09 US disclosed
US-20150191420-A1 ANTIBACTERIAL AGENTS TAXIS PHARMACEUTICALS, INC. 2015-07-09 US disclosed
US-8865736-B2 Antibacterial agents Biota Scientific Pty Ltd (AU) 2014-10-21 US disclosed
US-8865736-B2 Antibacterial agents Biota Scientific Pty Ltd (AU) 2014-10-21 US disclosed
US-8865736-B2 Antibacterial agents Biota Scientific Pty Ltd (AU) 2014-10-21 US disclosed
US-20130072520-A2 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-03-21 US disclosed
US-20130072520-A2 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-03-21 US disclosed
US-20130072520-A2 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-03-21 US disclosed
US-8088791-B2 Antibacterial agents Biots Scientific Management Pty Ltd (AU) 2012-01-03 US disclosed
US-8088791-B2 Antibacterial agents Biots Scientific Management Pty Ltd (AU) 2012-01-03 US disclosed
EP-1996180-B1 BENZAMIDE AND PYRIDYLAMIDE DERIVATIVES AS ANTIBACTERIAL AGENTS BIOTA EUROPE LTD (GB) 2011-08-03 EP disclosed
EP-1996180-B1 BENZAMIDE AND PYRIDYLAMIDE DERIVATIVES AS ANTIBACTERIAL AGENTS BIOTA EUROPE LTD (GB) 2011-08-03 EP disclosed
US-20100173933-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2010-07-08 US disclosed
US-20100173933-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2010-07-08 US disclosed
US-20100173933-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2010-07-08 US disclosed
EP-1996180-A1 ANTIBACTERIAL AGENTS Prolysis Limited (GB) 2008-12-03 EP disclosed
WO-2007107758-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2007-09-27 WO disclosed
WO-2007107758-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2007-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130072520-A2 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 POLB 364/4885L3MBTL1 703/4885ATP4A 2434/4885
US-20150191420-A1 ANTIBACTERIAL AGENTS ALK, ARG1, ROS1 POLB 435/4885L3MBTL1 377/4885ATP4A 2683/4885
US-20250179008-A1 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 POLB 364/4885L3MBTL1 703/4885ATP4A 2434/4885
US-20100173933-A1 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 POLB 364/4885L3MBTL1 703/4885ATP4A 2434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.